MA26811A1 - Gene de streptomyces avermitilis dirigeant le rapport des avermectines b2 :b1 - Google Patents

Gene de streptomyces avermitilis dirigeant le rapport des avermectines b2 :b1

Info

Publication number
MA26811A1
MA26811A1 MA26511A MA26511A MA26811A1 MA 26811 A1 MA26811 A1 MA 26811A1 MA 26511 A MA26511 A MA 26511A MA 26511 A MA26511 A MA 26511A MA 26811 A1 MA26811 A1 MA 26811A1
Authority
MA
Morocco
Prior art keywords
avermitilated
avermectins
streptomyces
directing
gene
Prior art date
Application number
MA26511A
Other languages
English (en)
Inventor
Jonelle Stutzman-Engwall Kim
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26811A1 publication Critical patent/MA26811A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA26511A 1999-08-12 2002-02-07 Gene de streptomyces avermitilis dirigeant le rapport des avermectines b2 :b1 MA26811A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Publications (1)

Publication Number Publication Date
MA26811A1 true MA26811A1 (fr) 2004-12-20

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26511A MA26811A1 (fr) 1999-08-12 2002-02-07 Gene de streptomyces avermitilis dirigeant le rapport des avermectines b2 :b1

Country Status (37)

Country Link
US (8) US6248579B1 (fr)
EP (1) EP1200605B1 (fr)
JP (2) JP3688640B2 (fr)
KR (1) KR100486006B1 (fr)
CN (1) CN1186447C (fr)
AP (2) AP2002002417A0 (fr)
AR (1) AR021450A1 (fr)
AT (1) ATE283363T1 (fr)
AU (1) AU779756B2 (fr)
BG (1) BG106478A (fr)
BR (1) BR0013093A (fr)
CA (1) CA2381427A1 (fr)
CO (1) CO5290296A1 (fr)
CZ (1) CZ2002297A3 (fr)
DE (1) DE60016231T2 (fr)
EA (1) EA004569B1 (fr)
ES (1) ES2231214T3 (fr)
GT (2) GT200000138A (fr)
HK (1) HK1046536B (fr)
HR (1) HRP20020131A2 (fr)
HU (1) HUP0202517A2 (fr)
IL (1) IL147562A0 (fr)
IS (1) IS6249A (fr)
MA (1) MA26811A1 (fr)
MX (1) MXPA02001514A (fr)
NO (1) NO20020665D0 (fr)
OA (1) OA11997A (fr)
PA (1) PA8499201A1 (fr)
PE (1) PE20010697A1 (fr)
PL (1) PL353770A1 (fr)
PT (1) PT1200605E (fr)
SK (1) SK1382002A3 (fr)
TN (1) TNSN00170A1 (fr)
UY (1) UY26287A1 (fr)
WO (1) WO2001012822A1 (fr)
YU (1) YU8402A (fr)
ZA (1) ZA200201071B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516517A (en) * 1999-08-12 2003-10-31 Pfizer Prod Inc Mutations in the aveC allele of Streptomyces avermitilis gene that reduce the ratio of cyclohexyl B2:cyclohexyl B1 avermectins
EP1474396B9 (fr) 2002-02-05 2008-07-09 Bristol-Myers Squibb Company N-substitute3-hydroxy-4-pyridinones et compositions pharmaceutiques contenant ces derniers
SI1476539T1 (sl) 2002-02-12 2009-06-30 Pfizer Prod Inc Gen streptomyces avermitilis, ki uravnava razmerje B2:B1 avermektinov
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
WO2004067549A2 (fr) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptides diriges contre des autoanticorps resultant de l'intolerance au froid, et leur utilisation
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
EP0313297B1 (fr) 1987-10-23 1993-05-19 Pfizer Inc. Procédé de production d'aglycones d'avermectine et des cultures les contenant
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
ES2079436T3 (es) 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
DK0711349T3 (da) 1993-07-30 2003-11-24 Pfizer Gener, der koder for forgrenet alfaketosyredehydrogenasekompleks fra Streptomyces avermitilis
CN1040113C (zh) * 1993-10-05 1998-10-07 美国辉瑞有限公司 抗寄生虫药物多哇麦汀(doramectin)的中间体及其制备方法
FI942725A7 (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
CA2320031A1 (fr) * 1998-02-13 1999-08-19 Pfizer Products Inc. Gene de streptomyces avermitilis commandant le rapport d'avermectines b2/b1

Also Published As

Publication number Publication date
US6509159B2 (en) 2003-01-21
ZA200201071B (en) 2003-06-25
SK1382002A3 (en) 2002-11-06
JP3688640B2 (ja) 2005-08-31
US20030124607A1 (en) 2003-07-03
YU8402A (sh) 2006-03-03
BR0013093A (pt) 2002-08-13
EP1200605A1 (fr) 2002-05-02
HRP20020131A2 (en) 2003-12-31
JP2003507018A (ja) 2003-02-25
HK1046536B (zh) 2005-05-13
MXPA02001514A (es) 2002-07-02
AR021450A1 (es) 2002-07-17
ATE283363T1 (de) 2004-12-15
US20030129636A1 (en) 2003-07-10
US6248579B1 (en) 2001-06-19
US20050196777A1 (en) 2005-09-08
KR100486006B1 (ko) 2005-05-03
HUP0202517A2 (hu) 2002-11-28
DE60016231T2 (de) 2005-12-08
IS6249A (is) 2002-01-25
AU5702100A (en) 2001-03-13
IL147562A0 (en) 2002-08-14
PE20010697A1 (es) 2001-07-05
EA004569B1 (ru) 2004-06-24
JP2005198658A (ja) 2005-07-28
US20030134313A1 (en) 2003-07-17
NO20020665L (no) 2002-02-11
US6833263B2 (en) 2004-12-21
CN1370239A (zh) 2002-09-18
HK1046536A1 (en) 2003-01-17
PA8499201A1 (es) 2001-12-14
DE60016231D1 (de) 2004-12-30
AP2002002419A0 (en) 2002-03-31
CA2381427A1 (fr) 2001-02-22
EA200200057A1 (ru) 2002-06-27
OA11997A (en) 2006-04-18
CZ2002297A3 (cs) 2002-08-14
NO20020665D0 (no) 2002-02-11
PL353770A1 (en) 2003-12-01
TNSN00170A1 (fr) 2005-11-10
US7259241B2 (en) 2007-08-21
US7029887B2 (en) 2006-04-18
PT1200605E (pt) 2005-04-29
BG106478A (bg) 2004-02-27
CN1186447C (zh) 2005-01-26
US6511841B2 (en) 2003-01-28
CO5290296A1 (es) 2003-06-27
AU779756B2 (en) 2005-02-10
UY26287A1 (es) 2001-03-16
US20030129635A1 (en) 2003-07-10
ES2231214T3 (es) 2005-05-16
WO2001012822A1 (fr) 2001-02-22
AP2002002417A0 (en) 2002-03-31
KR20020022809A (ko) 2002-03-27
GT200000138A (es) 2002-02-02
US20010016350A1 (en) 2001-08-23
EP1200605B1 (fr) 2004-11-24
US20010024818A1 (en) 2001-09-27
GT200000138CA (es) 2002-02-02

Similar Documents

Publication Publication Date Title
MXPA03001775A (es) Derivados de nucleosidos.
AU5515901A (en) Gamma-phosphoester nucleoside triphosphates
MX237254B (es) Inhibidores sglt2 de glucosidos c-arilo.
ATE256694T1 (de) Ketolid-antibiotika
AU2001278694A1 (en) Avermectin derivatives
AU2002330717A1 (en) Monosaccharide derivatives
MA26811A1 (fr) Gene de streptomyces avermitilis dirigeant le rapport des avermectines b2 :b1
ZA991138B (en) Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins.
MA26813A1 (fr) Gene de streptomyces avermitilis commandant le rapport des avermectines b2 :b1
PT1140068E (pt) Formulacoes de doramectina
GB9916803D0 (en) Flavonoid biosynthesis
EP1076093A4 (fr) Gene de synthase de sakuranetine
TWI341330B (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
GB0313937D0 (en) Avermectin B1 monosaccharide derivatives having an aminosulfonyloxy substituentin the 4'-position
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU2002215965A1 (en) Pyranoside derivatives
EP1147118A4 (fr) Disaccharides a liaison alpha non substitues
AU2001277712A1 (en) Avermectin derivatives
GB0026611D0 (en) Nucleoside derivatives
GB0021285D0 (en) Nucleoside derivatives
AU7809100A (en) Fluidic multiplexer